APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $879 | -55.9% | 23,099 | +5.5% | 0.01% | -53.8% |
| Q2 2023 | $1,995 | +11.0% | 21,896 | -19.7% | 0.01% | +8.3% |
| Q1 2023 | $1,797 | +28.7% | 27,251 | +0.9% | 0.01% | +20.0% |
| Q4 2022 | $1,396 | -99.9% | 27,002 | -3.1% | 0.01% | -28.6% |
| Q3 2022 | $1,903,000 | +242.9% | 27,862 | +127.2% | 0.01% | +250.0% |
| Q2 2022 | $555,000 | -30.9% | 12,265 | -22.3% | 0.00% | 0.0% |
| Q1 2022 | $803,000 | +16.0% | 15,795 | +7.9% | 0.00% | +33.3% |
| Q4 2021 | $692,000 | +119.7% | 14,636 | +53.2% | 0.00% | +50.0% |
| Q3 2021 | $315,000 | -32.1% | 9,551 | +30.1% | 0.00% | -33.3% |
| Q2 2021 | $464,000 | +73.8% | 7,344 | +17.8% | 0.00% | +200.0% |
| Q1 2021 | $267,000 | -7.6% | 6,232 | +23.2% | 0.00% | -50.0% |
| Q4 2020 | $289,000 | – | 5,059 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |